TABLE 6F - REVISED PROCEDURE CODE TITLES
Procedure Code	Description	O.R.	MDC	MS-DRG
3E00X0M	Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach	N		
3E0130M	Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach	N		
3E0230M	Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach	N		
3E0300M	Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach	N		
3E0330M	Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach	N		
3E0400M	Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach	N		
3E0430M	Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach	N		
3E0500M	Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach	N		
3E0530M	Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach	N		
3E0600M	Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach	N		
3E0630M	Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach	N		
3E0930M	Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach	N		
3E0970M	Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening	N		
3E09X0M	Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach	N		
3E0A30M	Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach	N		
3E0B30M	Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach	N		
3E0B70M	Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening	N		
3E0BX0M	Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach	N		
3E0C30M	Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach	N		
3E0C70M	Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening	N		
3E0CX0M	Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach	N		
3E0D30M	Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach	N		
3E0D70M	Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening	N		
3E0DX0M	Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach	N		
3E0E30M	Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach	N		
3E0E70M	Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening	N		
3E0E80M	Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic	N		
3E0F30M	Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach	N		
3E0F70M	Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening	N		
3E0F80M	Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic	N		
3E0G30M	Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach	N		
3E0G70M	Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening	N		
3E0G80M	Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic	N		
3E0H30M	Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach	N		
3E0H70M	Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening	N		
3E0H80M	Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic	N		
3E0J30M	Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach	N		
3E0J70M	Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening	N		
3E0J80M	Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic	N		
3E0K30M	Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach	N		
3E0K70M	Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening	N		
3E0K80M	Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic	N		
3E0L30M	Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach	N		
3E0L70M	Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening	N		
3E0M30M	Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach	N		
3E0M70M	Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening	N		
3E0N30M	Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach	N		
3E0N70M	Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening	N		
3E0N80M	Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic	N		
3E0P30M	Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach	N		
3E0P70M	Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening	N		
3E0P80M	Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic	N		
3E0Q00M	Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach	N		
3E0Q30M	Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach	N		
3E0Q70M	Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening	N		
3E0R30M	Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach	N		
3E0S30M	Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach	N		
3E0U30M	Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach	N		
3E0V30M	Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach	N		
3E0W30M	Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach	N		
3E0Y30M	Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach	N		
3E0Y70M	Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening	N		

	Notes:
